NTRA
Natera Inc
Halal Rating :
Last Price
$158.91
Last updated:
Market Cap
-
7D Change
-6.14%
1 Year Change
138.32%
Company Overview
Industries
Exchange
Next Earnings Date
Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services. The company specializes in cell-free DNA testing, with applications in reproductive health, oncology, and organ transplantation. Their primary products include Panorama (non-invasive prenatal testing), Signatera (personalized cancer monitoring), and Prospera (organ transplant assessment).
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $439.76m | $482.24m | - | $3.14m | 0.00% | 0.65% |
| June 30, 2024 | $413.35m | $460.38m | - | $3.13m | 0.00% | 0.68% |
| March 31, 2024 | $367.74m | $445.18m | - | $3.12m | 0.00% | 0.70% |
Company Impact
Help us evaluate Natera Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.